CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,092
- in 3 filings, $19K under 10b5-1 plans
Net −$19,092. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-07 | Eaton Bruce EVP, CBO AND CTO | Sale | −346 | $11.10 | $4K | 64,290 |
| 2023-01-10 | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | Sale | −1,752 | $8.16 | $14K | 80,530 |
| 2022-12-05 | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | Sale | −193 | $10.23 | $2K | 82,282 |
| 2022-12-05 | Eaton Bruce EVP, CHIEF BUSINESS OFFICER | Sale | −102 | $10.23 | $1K | 64,636 |
| 2022-11-08 | Eaton Bruce EVP, CHIEF BUSINESS OFFICER | Sale | −289 | $11.02 | $3K | 64,738 |
| 2022-09-06 | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | Sale | −192 | $15.01 | $3K | 82,475 |
| 2022-09-06 | Eaton Bruce EVP, CHIEF BUSINESS OFFICER | Sale | −101 | $15.01 | $2K | 65,027 |
| 2022-08-09 | Eaton Bruce EVP, CHIEF BUSINESS OFFICER | Sale | −293 | $18.60 | $5K | 65,128 |
| 2022-07-18 | Mei Baisong SVP, CHIEF MEDICAL OFFICER | Grant or award | +58,372 | 58,372 | ||
| 2022-07-18 | Mei Baisong SVP, CHIEF MEDICAL OFFICER | Grant or award · Stock Option (right to buy) | +171,602 | 171,602 | ||
| 2022-06-15 | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER | Sale | −5,145 | $10.06 | $52K | 68,349 |
| 2022-06-09 | Connaughton Bernadette Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-09 | Reeve Emma Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-09 | Vaishnaw Akshay Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-09 | Scadden David Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-09 | Hopfield Jessica Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-09 | Hirsch Andrew Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-09 | Chatterjee Meeta Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-03 | Eaton Bruce EVP, CHIEF BUSINESS OFFICER | Sale | −1,123 | $11.54 | $13K | 65,421 |
| 2022-06-03 | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | Sale | −1,527 | $11.54 | $18K | 82,667 |
Page 7 of 15 · 283 trades